GUAA_LEPIN
ID GUAA_LEPIN Reviewed; 603 AA.
AC Q8F4F4;
DT 01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2004, sequence version 2.
DT 03-AUG-2022, entry version 112.
DE RecName: Full=Probable GMP synthase [glutamine-hydrolyzing];
DE EC=6.3.5.2;
DE AltName: Full=GMP synthetase;
DE AltName: Full=Glutamine amidotransferase;
GN Name=guaA; OrderedLocusNames=LA_2087;
OS Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain
OS 56601).
OC Bacteria; Spirochaetes; Leptospirales; Leptospiraceae; Leptospira.
OX NCBI_TaxID=189518;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=56601;
RX PubMed=12712204; DOI=10.1038/nature01597;
RA Ren S.-X., Fu G., Jiang X.-G., Zeng R., Miao Y.-G., Xu H., Zhang Y.-X.,
RA Xiong H., Lu G., Lu L.-F., Jiang H.-Q., Jia J., Tu Y.-F., Jiang J.-X.,
RA Gu W.-Y., Zhang Y.-Q., Cai Z., Sheng H.-H., Yin H.-F., Zhang Y., Zhu G.-F.,
RA Wan M., Huang H.-L., Qian Z., Wang S.-Y., Ma W., Yao Z.-J., Shen Y.,
RA Qiang B.-Q., Xia Q.-C., Guo X.-K., Danchin A., Saint Girons I.,
RA Somerville R.L., Wen Y.-M., Shi M.-H., Chen Z., Xu J.-G., Zhao G.-P.;
RT "Unique physiological and pathogenic features of Leptospira interrogans
RT revealed by whole-genome sequencing.";
RL Nature 422:888-893(2003).
CC -!- FUNCTION: Catalyzes the synthesis of GMP from XMP. {ECO:0000250}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + H2O + L-glutamine + XMP = AMP + diphosphate + GMP + 2
CC H(+) + L-glutamate; Xref=Rhea:RHEA:11680, ChEBI:CHEBI:15377,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57464, ChEBI:CHEBI:58115,
CC ChEBI:CHEBI:58359, ChEBI:CHEBI:456215; EC=6.3.5.2;
CC -!- PATHWAY: Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln
CC route): step 1/1.
CC -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE010300; AAN49286.2; -; Genomic_DNA.
DR RefSeq; NP_712268.2; NC_004342.2.
DR RefSeq; WP_000234667.1; NC_004342.2.
DR AlphaFoldDB; Q8F4F4; -.
DR SMR; Q8F4F4; -.
DR STRING; 189518.LA_2087; -.
DR EnsemblBacteria; AAN49286; AAN49286; LA_2087.
DR GeneID; 61141728; -.
DR KEGG; lil:LA_2087; -.
DR PATRIC; fig|189518.3.peg.2080; -.
DR HOGENOM; CLU_014340_0_2_12; -.
DR InParanoid; Q8F4F4; -.
DR OMA; KRKIIGH; -.
DR UniPathway; UPA00189; UER00296.
DR Proteomes; UP000001408; Chromosome I.
DR GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0003921; F:GMP synthase activity; IBA:GO_Central.
DR GO; GO:0016462; F:pyrophosphatase activity; IEA:InterPro.
DR GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR GO; GO:0006177; P:GMP biosynthetic process; IBA:GO_Central.
DR CDD; cd01742; GATase1_GMP_Synthase; 1.
DR CDD; cd01997; GMP_synthase_C; 1.
DR Gene3D; 3.40.50.620; -; 1.
DR Gene3D; 3.40.50.880; -; 1.
DR InterPro; IPR029062; Class_I_gatase-like.
DR InterPro; IPR017926; GATASE.
DR InterPro; IPR001674; GMP_synth_C.
DR InterPro; IPR004739; GMP_synth_GATase.
DR InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR InterPro; IPR022310; NAD/GMP_synthase.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR Pfam; PF00117; GATase; 1.
DR Pfam; PF00958; GMP_synt_C; 1.
DR Pfam; PF02540; NAD_synthase; 1.
DR SUPFAM; SSF52317; SSF52317; 1.
DR TIGRFAMs; TIGR00888; guaA_Nterm; 1.
DR PROSITE; PS51273; GATASE_TYPE_1; 1.
DR PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE 3: Inferred from homology;
KW ATP-binding; Glutamine amidotransferase; GMP biosynthesis; Ligase;
KW Nucleotide-binding; Purine biosynthesis; Reference proteome.
FT CHAIN 1..603
FT /note="Probable GMP synthase [glutamine-hydrolyzing]"
FT /id="PRO_0000140142"
FT DOMAIN 6..195
FT /note="Glutamine amidotransferase type-1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT DOMAIN 196..392
FT /note="GMPS ATP-PPase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00886"
FT REGION 432..505
FT /note="Insert"
FT ACT_SITE 81
FT /note="Nucleophile"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT ACT_SITE 170
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT ACT_SITE 172
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT BINDING 224..230
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00886"
SQ SEQUENCE 603 AA; 67913 MW; 9C8920DEEA2C41B7 CRC64;
MVIHKKIAVV DFGGQYAHLI ASRIRRLGAY TEILSNEEPI SNYQKYSGII LSGGPESVYE
PNSPTVTTRI FDLGIPILGI CYGHQLIMKL LGGVVERSGT GEYGPASLQL HGTNGNSILK
NFVGGEQVWM NHADEVVKLP EGFSKIAFSK DCGYAVVANS SKKIFGIQFH AEVSHSEKGS
VLLDNFIQIC GVSKTWGIDQ FLKEKIKEIQ ETVKQEQKIF MLVSGGVDST VSYLLLCKAL
GAERVLGFLI DTGFMRKDEV VSLQKKLTFQ NIHLTVRDES SLFYKSLKDK SDPEEKRKIV
GNLFLEARDR AVKDLDLEYG DWLLGQGTIY PDTIESGGTK HSHTIKTHHN RVEAIQKLIE
QGKVIEPIRD LYKDEVRDLG VLLGLESEWV GRHPFPGPGL VVRMLAVEKK GTDKDQLEID
SYLSTQDGLS GKILPIASVG VKGDRRSYAN CVVLNDIETD WNTLDRVATH LSNRFSFINR
VVLLPFESDL KKWNFQFTGM QLDKKCSDLL READFTVESV IRKLGLYNKI WQMPVVLLPI
GEKENEKSIV LRPVESQEAM TANFFRMERS VLQEIKIEVL KIPEIRYLFF DLTNKPPGTI
EWE